Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Cantab and Chemo-Sero to develop chickenpox and shingles vaccines

Jan. 19, 1998

No Comments

Daclizumab efficacy demonstrated in transplant recipients

Jan. 16, 1998

No Comments

Novel polyspecific antibody-agent conjugates from Immunomedics

Jan. 16, 1998

No Comments

Dysentery vaccine technology available for licensing from NIH

Jan. 15, 1998

No Comments

Vertex describes new IMPDH inhibitors

Jan. 14, 1998

No Comments

Novel thalidomide prodrugs reported in patent literature

Jan. 12, 1998

No Comments

ABX-CBL evaluated in phase II GVHD trial

Jan. 7, 1998

No Comments

New immunosuppressants in the pipeline at Merck & Co.

Dec. 31, 1997

No Comments

MedImmune and BioTransplant plan to test MEDI-507 for graft-vs.-host disease

Dec. 29, 1997

No Comments

CY-1503 reduces reperfusion injury in a dog lung allograft model

Dec. 22, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immune
RSS

Cantab and Chemo-Sero to develop chickenpox and shingles vaccines

Daclizumab efficacy demonstrated in transplant recipients

Novel polyspecific antibody-agent conjugates from Immunomedics

Dysentery vaccine technology available for licensing from NIH

Vertex describes new IMPDH inhibitors

Novel thalidomide prodrugs reported in patent literature

ABX-CBL evaluated in phase II GVHD trial

New immunosuppressants in the pipeline at Merck & Co.

MedImmune and BioTransplant plan to test MEDI-507 for graft-vs.-host disease

CY-1503 reduces reperfusion injury in a dog lung allograft model

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

Phase III AMD miss leaves BLA Outlook same with bevacizumab

Immune RSS

Immune
RSS